/PRNewswire/ Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies†, today announced that the.
Börse Express - Johnson & Johnson Vision erhält FDA-Zulassung und CE-Kennzeichnung für Phakoemulsifikationsmaschine der nächsten Generation, VERITAS(TM) Vision System boerse-express.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boerse-express.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson Vision Reinforces Sustainability Commitment
Published 4 hours ago
Solar Power
Business will source 100% of its electricity from renewable sources by 2025 and achieve carbon neutrality by 2030
New deal signed with JEA as part of its SolarMax program will ensure 100% renewable electricity at its global headquarters in Jacksonville, Florida
New sustainability vision launched for ACUVUE® brand contact lenses with all ACUVUE® contact lenses to be made using renewable electricity
JACKSONVILLE, Fla., APRIL 22, 2021 /CSRwire/– Johnson & Johnson Vision , a global leader in eye health and manufacturer of ACUVUE® brand contact lenses, today announced that it has signed a 10-year deal with JEA1 which will see 100% of the electricity at its global headquarters in Jacksonville, Florida come from solar power.
Share this article
Share this article
SANTA ANA, Calif., April 21, 2021 /PRNewswire/ Johnson & Johnson Vision , a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies , today announced the FDA 510(k) clearance and CE mark of its next-generation phacoemulsification innovation, the VERITAS™ Vision System
1. The high-performance phacoemulsification system features technologies that allow surgeons to guide through any lens density with less surge and more stability. The new system also provides advancements in ergonomics to further enhance usability during cataract surgery.
(PRNewsfoto/Johnson & Johnson Vision)
More than 90% of people develop cataracts by the age of 65,
2 and cataract surgery is one of the most common outpatient procedures performed today with a success rate of approximately 98%.
Acelera Johnson & Johnson Medical Devices la digitalización de la atención Médica | Comunicados | Edición América efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.